An expert in benign and malignant hematology with specialty interests in breast, lung, prostate, and gastrointestinal cancers, Dr. Andrew Horodner attended medical school at the University of Arizona, trained in internal medicine at UC-Irvine and completed a fellowship in hematology/oncology at Harbor UCLA/Kaiser Permanente with distinction. Dr. Horodner is Chairman of the Tumor Board and Vice-Chair of the Oncology Committee at Torrance Memorial Medical Center, where he also serves as Chairman of the Transitional Care Unit and Medicine Performance Improvement Committees and Vice-Chair of the Department of Medicine. Dr. Horodner is a member of the Tumor Board at Little Company of Mary Hospital. Additionally, he is a member of the Pharmacy and Therapeutics, Medical Executive and Breast Cancer Program Committees at Torrance Memorial. Dr. Horodner is a clinical instructor in the oncology department at Harbor UCLA.